Determining Baseline Respiratory Duty Cycles in Subjects With and Without Airway Hyperresponsiveness

NCT ID: NCT04001465

Last Updated: 2020-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-14

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates the inspiratory duty cycle in subjects with and without airway hyper-responsiveness both at rest and during a bronchoprovocation challenge. The primary goal is to determine an average inspiratory duty cycle for standard use in the calculation of bronchoprovocation test results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At least fifteen subjects with airway hyper-responsiveness and fifteen without airway hyper-responsiveness will be recruited to participate in this randomized, crossover study. Subjects will complete 2 methacholine challenges at least 24 hours apart. One methacholine challenge will entail the volumetric method using a vibrating mesh nebulizer. The second methacholine challenge will be performed identically except that the nebulizer will be fitted onto an ultrasonic nebulizer so as to measure the inspiratory duty cycle throughout the bronchoprovocation challenge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Hyper Responsiveness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Volumetric methacholine challenge

Methacholine challenge performed per the volumetric method using an Aerogen Solo vibrating mesh nebulizer

Group Type ACTIVE_COMPARATOR

Volumetric methacholine challenge unmodified

Intervention Type PROCEDURE

Bronchoprovocation challenge performed per volumetric method

Methacholine challenge with spirometer

Methacholine challenge performed per the volumetric method using an Aerogen Solo vibrating mesh nebulizer fitted with an ultrasonic spirometer

Group Type ACTIVE_COMPARATOR

Modified volumetric methacholine challenge

Intervention Type PROCEDURE

Bronchoprovocation challenge performed per volumetric method modified to include use of ultrasonic spirometer fitted with vibrating mesh nebulizer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Volumetric methacholine challenge unmodified

Bronchoprovocation challenge performed per volumetric method

Intervention Type PROCEDURE

Modified volumetric methacholine challenge

Bronchoprovocation challenge performed per volumetric method modified to include use of ultrasonic spirometer fitted with vibrating mesh nebulizer

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be 18 years of age or older
* Participants with airway hyper-responsiveness must have a positive methacholine challenge
* Forced expiratory volume (FEV1) of at least 65% of predicted (based on age, height, and gender)
* Participants without airway hyper-responsiveness must have a negative methacholine challenge
* All participants must avoid strenuous exercise on test days
* No short-acting beta-2 agonist use within 6 hours of study visit

Exclusion Criteria

* Participants without known airway hyper-responsiveness cannot have a current or historical respiratory condition (e.g. asthma, allergic rhinitis)
* Participants cannot be taking long-acting bronchodilators
* Participants cannot be pregnant or lactating
* Participants cannot have cardiovascular problems
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Saskatchewan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Don Cockcroft

Professor, Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Don Cockcroft, MD

Role: PRINCIPAL_INVESTIGATOR

University of Saskatchewan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asthma Research Lab - University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TiTtot-2019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

IMT in Hypercapnic Patients With COPD
NCT02914093 TERMINATED NA
Breathing Exercises on Lung Function
NCT06472167 RECRUITING NA